Clinical Trials Logo
  1. Home
  2. Myopia
  3. NCT01475877
  4. Details
NCT01475877 Clinical Trial

Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

Myopia Clinical Trial

Official title:
Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01475877
Other study ID # MAC-02-11
Secondary ID
Status Completed
Phase Phase 4
First received November 7, 2011
Last updated May 1, 2016
Start date May 2011
Est. completion date May 2012

Study information
Verified date May 2016
Source Virdi Eye Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Recruitment information / eligibility
Status Completed
Enrollment 20
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- male or female at least 18 years of age,

- no other ocular studies with 15 days prior to dosing,

- BCVA 20/200 or better,

- return for study visits and follow instructions from investigator and staff,

- self administer test article

Exclusion Criteria:

- Ocular inflammation,

- hypersensitivity to bromfenac or nepafenac,

- any corneal pathology,

- have had radial keratotomy,

- corneal transplant or corneal refractive surgery in the last two years

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Drug:
• Bromfenac
Bromfenac 0.09% 1 drop in study eyes q day

Locations
Country Name City State
United States Virdi Eye Clinic and Laser Vision Center Rock Island Illinois

Sponsors (1)
Lead Sponsor Collaborator
Virdi Eye Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Post-PRK pain 7 days No
Secondary Post-PRK epithelial healing 7 days No
See also
  Status Clinical Trial Phase
Recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A